The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate
Clinical trial NCT00427219 · COMPLETED
Trial details
- NCT number
- NCT00427219
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-23
- Primary completion
- 2008-02-27
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.